The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma - Beeh, K M; Kanniess, F; Wagner, F; Schilder, C; Naudts, I; Hammann-Haenni, A; Willers, J; Stocker, H; Mueller, P; Bachmann, M Fand all (J Allergy Clin Immunol, 2013)